Skip to content
10-Q

Quarterly Report

SUTRO BIOPHARMA, INC. STRO

0000950170-25-105219

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 84.77M sh
Shares Diluted Q2 2025 · Jun 30, 2025 84.58M sh
Shares Diluted Q2 2025 · Jun 30, 2025 83.85M sh
Shares Diluted Q2 2025 · Jun 30, 2024 81.22M sh
Shares Diluted Q2 2025 · Jun 30, 2024 71.34M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$112.61M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$55.29M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $64.03M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $190.3M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $90.79M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$32.11M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$25.81M
Stockholders Equity Q2 2025 · Dec 31, 2024 $44.6M
Stockholders Equity Q2 2025 · Jun 30, 2024 $152.18M
Stockholders Equity Q2 2025 · Mar 31, 2024 $98.02M
Stockholders Equity Q2 2025 · Dec 31, 2023 $149.65M
Current Liabilities Q2 2025 · Jun 30, 2025 $74.25M
Current Liabilities Q2 2025 · Dec 31, 2024 $131.89M
Total Liabilities Q2 2025 · Jun 30, 2025 $294.47M
Total Liabilities Q2 2025 · Dec 31, 2024 $342.61M
Current Assets Q2 2025 · Jun 30, 2025 $231.63M
Current Assets Q2 2025 · Dec 31, 2024 $343.31M
Total Assets Q2 2025 · Jun 30, 2025 $262.36M
Total Assets Q2 2025 · Dec 31, 2024 $387.21M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.14
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.04
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.59
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.49
Eps Diluted Q2 2025 · Mar 31, 2024 −$0.59
Eps Basic Q2 2025 · Jun 30, 2025 −$0.14
Eps Basic Q2 2025 · Jun 30, 2025 −$1.04
Eps Basic Q2 2025 · Jun 30, 2024 −$0.59
Eps Basic Q2 2025 · Jun 30, 2024 −$1.49
Eps Basic Q2 2025 · Mar 31, 2024 −$0.59
Sga Expense Q2 2025 · Jun 30, 2025 $10.34M
Sga Expense Q2 2025 · Jun 30, 2025 $23.62M
Sga Expense Q2 2025 · Jun 30, 2024 $12.37M
Sga Expense Q2 2025 · Jun 30, 2024 $25.09M
Rd Expense Q2 2025 · Jun 30, 2025 $38.33M
Rd Expense Q2 2025 · Jun 30, 2025 $89.92M
Rd Expense Q2 2025 · Jun 30, 2024 $62.02M
Rd Expense Q2 2025 · Jun 30, 2024 $118.9M
Net Income Q2 2025 · Jun 30, 2025 −$11.5M
Net Income Q2 2025 · Jun 30, 2025 −$87.47M
Net Income Q2 2025 · Mar 31, 2025 −$75.97M
Net Income Q2 2025 · Jun 30, 2024 −$48.02M
Net Income Q2 2025 · Jun 30, 2024 −$106.23M
Net Income Q2 2025 · Mar 31, 2024 −$58.21M
Operating Income Q2 2025 · Jun 30, 2025 −$3.35M
Operating Income Q2 2025 · Jun 30, 2025 −$71.86M
Operating Income Q2 2025 · Jun 30, 2024 −$48.69M
Operating Income Q2 2025 · Jun 30, 2024 −$105.28M
Revenue Q2 2025 · Jun 30, 2025 $63.75M
Revenue Q2 2025 · Jun 30, 2025 $81.14M
Revenue Q2 2025 · Jun 30, 2024 $25.71M
Revenue Q2 2025 · Jun 30, 2024 $38.71M